Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DYRK1A | Q13627 | 3/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.41 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 1/20 | 0.38 |
| ▸ | HTR2C | P28335 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.38 |
| ▸ | OPRM1 | P35372 | 2/20 | 0.34 |
| ▸ | OPRL1 | P41146 | 2/20 | 0.34 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.34 |
| ▸ | CTSK | P43235 | 1/20 | 0.33 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.32 |
| ▸ | CDK1 | P06493 | 1/20 | 0.32 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.32 |
| ▸ | GSK3B | P49841 | 1/20 | 0.32 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.32 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.32 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.32 |
| ▸ | GLA | P06280 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8831803 | 1.00 | DYRK1A (0.41) | DYRK1ATAAR1MCHR1HTR2AHTR2C | |
| SCHEMBL7822706 | 1.00 | DYRK1A (0.41) | DYRK1ATAAR1MCHR1HTR2AHTR2C | |
| SCHEMBL7828493 | 0.68 | MCHR1 (0.40) | MCHR1L3MBTL1KDM4E | |
| SCHEMBL7816458 | 0.68 | MCHR1 (0.40) | MCHR1L3MBTL1KDM4E | |
| SCHEMBL8840806 | 0.66 | MCHR1 (0.43) | DYRK1ATAAR1MCHR1HTR2AHTR2C | |
| SCHEMBL4727564 | 0.62 | TAAR1 (0.62) | DYRK1ATAAR1CCNB2CDK1CCNB1 | |
| SCHEMBL24896324 | 0.62 | MAP2 (0.48) | DYRK1AMCHR1HTR2AHTR2CKCNH2 | |
| SCHEMBL17885103 | 0.62 | HTR2A (0.43) | DYRK1ATAAR1MCHR1HTR2AHTR2C | |
| SCHEMBL31743436 | 0.62 | MAP2 (0.48) | DYRK1AMCHR1HTR2AHTR2CKCNH2 | |
| SCHEMBL11756901 | 0.62 | TAAR1 (0.54) | DYRK1ATAAR1MCHR1CCNB2CDK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0749313-A4 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | LILLY CO ELI (US) | 2001-10-24 | — | — | EP | disclosed |
| US-5861410-A | TREATING A FUNCTIONAL BOWEL DISORDER | ELI LILLY AND COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| US-5861408-A | SEROTONIN RECEPTOR ANTAGONISTS, INHIBITORS OF SEROTONIN-INDUCED COLON CONCTRACTIONS, FOR TREATING GASTROINTESTINAL DISORDERS | ELI LILLY AND COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| US-5861409-A | Tetrahydro-beta-carbolines | ELI LILLY AND COMPANY (US) | 1999-01-19 | — | — | US | disclosed |
| US-5736544-A | ADMINISTERING TO TREAT MIGRAINE HEADACHES IN MAMMALS | ELI LILLY AND COMPANY (US) | 1998-04-07 | — | — | US | disclosed |
| US-5705519-A | ADMINISTERING A SUBSTITUTED INDOLE TO A MAMMAL | ELI LILLY AND COMPANY (US) | 1998-01-06 | — | — | US | disclosed |
| US-5688807-A | ANTIDEPRESSANTS, ANXIETY, UROGENITAL DISORDERS, HYPOTENSIVES, CARDIOVASCULAR DISORDERS | ELI LILLY AND COMPANY (US) | 1997-11-18 | — | — | US | disclosed |
| US-5663178-A | 5-HT2 RECEPTOR ANTABONISTS | ELI LILLY AND COMPANY (US) | 1997-09-02 | — | — | US | disclosed |
| US-5643916-A | 5-HT(2B) RECEPTOR MODULATORS | ELI LILLY AND COMPANY (US) | 1997-07-01 | — | — | US | disclosed |
| US-5629317-A | SEROTONIN ANTAGONIST | ELI LILLY AND COMPANY (US) | 1997-05-13 | — | — | US | disclosed |
| EP-0749313-A1 | METHOD FOR TREATING 5HT 2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1996-12-27 | — | — | EP | disclosed |
| WO-1996024351-A1 | TETRAHYDRO-BETA-CARBOLINES, OCTAHYDRO-INDOLO-[2,3-c]QUINOLINES AND OCTAHYDRO-INDOLO-[2,3-c]-QUINUCLIDINES | ELI LILLY AND COMPANY (US) | 1996-08-15 | — | — | WO | disclosed |
| WO-1995024200-A1 | METHOD FOR TREATING 5HT2B RECEPTOR RELATED CONDITIONS | ELI LILLY AND COMPANY (US) | 1995-09-14 | — | — | WO | disclosed |